These results suggest that neuronal CaMKK2 deficiency can effectively program the tumor-infiltrating myeloid population from a DAM-like phenotype (associated with ICB resistance) to a more immunostimulatory phenotype. The gene discussed is CAMKK2; the disease is neoplasm.